FDA Brief

Company record

Empower Clinic Services, LLC dba Empower Pharmacy

3 FDA warning letters since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Empower Clinic Services, LLC dba Empower Pharmacy.

Warning letters

  1. Empower Clinic Services, LLC dba Empower Pharmacy

    FDA warned Empower Pharmacy over unapproved compounded semaglutide/tirzepatide copies and sterile manufacturing deficiencies that put patients at risk.

    High risk
  2. Empower Clinic Services, LLC dba Empower Pharmacy

    FDA warns Empower Pharmacy that insanitary conditions in sterile drug compounding put patients at risk.

    High risk
  3. Empower Clinic Services, LLC dba Empower Pharmacy

    FDA warns Empower Pharmacy its compounded drugs missed outsourcing-facility conditions, including labeling and adverse-event reporting.

    Medium